Akintunde Bello, Ph.D.
Board Member
Xilio Therapeutics, Inc. (XLO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Akintunde Bello, Ph.D.
Akintunde Bello, Ph.D. is recorded as Board Member at Xilio Therapeutics, Inc. (XLO). Xilio Therapeutics, Inc. reported in an 8-K filed June 12, 2026 that Akintunde Bello, Ph.D. was appointed Class II director, effective June 10, 2026. Xilio Therapeutics, Inc. reported in an 8-K filed June 10, 2025 that Akintunde Bello, Ph.D. was appointed Class II director, effective June 10, 2025.
“The Company's stockholders elected Akintunde Bello, Ph.D., Daniel Curran, M.D., Robert Ross, M.D. and Yuan Xu, Ph.D., as Class II directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified.”
“Effective June 10, 2025, the Board of Directors (the "Board") of Xilio Therapeutics, Inc. (the "Company") increased the size of the Board to ten directors and, on the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Akintunde Bello, Ph.D., as a Class II director of the Company, with a term expiring at the Company's 2026 annual meeting of stockholders, to serve until his respective successor has been duly elected and qualified or until his earlier resignation, death, or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xilio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- René Russo CEO, Board Member
- Sara M. Bonstein Chairman, Board Member
- Kevin Brennan CFO, Chief Accounting Officer
- Christopher Frankenfield COO
- Akintunde Bello Board Member
- Aoife Brennan Board Member
- Aoife Brennan, M.D. Board Member
- Cheryl Blanchard Board Member
- Cheryl R. Blanchard, Ph.D. Board Member
- Daniel Curran Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.